Latest News for: mhra

Edit

MHRA statement on new review of paracetamol safety during pregnancy (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 17 Jan 2026
Dr Alison Cave, Chief Safety Officer at the MHRA, said. ... Members of the public and healthcare professionals are encouraged to report any suspected side effect from medicines, including paracetamol, to the MHRA's Yellow Card scheme.
Edit

Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 16 Jan 2026
... App stores for MHRA Yellow Card ... MHRA - Medicines and Healthcare products Regulatory Agency published this content on January 16, 2026, and is solely responsible for the information contained herein.
Edit

Medicines and Healthcare products Regulatory Agency Privacy Notice (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 14 Jan 2026
dataprotection@mhra.gov.uk. If you have queries about how the Agency protects and uses your personal data, please contact dataprotection@mhra.gov.uk in the first instance ... MHRA ... MHRA - Medicines and ...
Edit

techUK's call for evidence for MHRA consultation on AI regulation (techUK Ltd)

Public Technologies 13 Jan 2026
) Opportunities 13 Jan 2026 techUK is seeking evidence to inform its response to the MHRA consultation on AI regulation, gathering views from ...
Edit

WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic

PR Newswire 13 Jan 2026
Chris Chen, CEO of WuXi Biologics, commented, "We are delighted to receive GMP certification from MHRA, a testament to our steadfast commitment to the highest global quality standards.
Edit

WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic (Wuxi Biologics (Cayman) Inc)

Public Technologies 13 Jan 2026
) WuXi Biologics Obtains GMP Certification from UK MHRA for Commercial Manufacturing of an Ophthalmic Biologic ... products Regulatory Agency (MHRA) for commercial manufacturing of an ophthalmic biologic.
Edit

Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 13 Jan 2026
Data from the Medicines and Healthcare products Regulatory Agency (MHRA) shows clinical trial applications received rose by 9 per cent between January and November 2025 compared with the same period in 2024 ... MHRA Chief Executive Lawrence Tallon said..
Edit

UK authorities link crypto entrepreneur to major illegal drug operation

Cryptopolitan 10 Jan 2026
Now, an investigation carried out by UK newspaper The Guardian has linked one of the crypto entrepreneurs, Tariq Faisal, to the industrial estate unit in Northampton that was raised by the Medicines and Healthcare Products Regulatory Agency (MHRA).
Edit

MHRA strengthening dependency and addiction warnings on medicines used to treat pain, anxiety, and insomnia (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 08 Jan 2026
Dr Alison Cave, MHRA Chief Safety Officer, said. ... The MHRA will continue to monitor the safety of gabapentinoids, benzodiazepines and z-drugs and will take further regulatory action if this is appropriate.
Edit

Improving information supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 08 Jan 2026
MHRA - Medicines and Healthcare products Regulatory Agency published this content on ...
Edit

Professor Sir Aziz Sheikh: Towards next-generation pharmacovigilance capabilities for the UK (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 08 Jan 2026
For decades, the UK has been recognised for its leadership in pharmacovigilance, underpinned by the MHRA's Yellow Card scheme, which continues to play a vital role in detecting important safety signals early.
Edit

Nirogacestat hydrobromide approved to treat desmoid tumours (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 07 Jan 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 January 2026) approved the medicine Nirogacestat hydrobromide (Ogsiveo) for the treatment of progressing desmoid tumours in adults.
Edit

MHRA authorises Nucala (mepolizumab) in the UK for the treatment of uncontrolled COPD of an eosinophilic phenotype for patients on triple therapy*

Pharmiweb 06 Jan 2026
GSK) today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has approved Nucala (mepolizumab), a ... MHRA approval was granted on December 29th 2025.
Edit

MHRA welcomes Professor Jacob George as he starts Chief Medical and Scientific Officer role (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 05 Jan 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) welcomes Professor Jacob George, who starts his role as the MHRA's Chief Medical and Scientific Officer (CMSO) today (5 January 2026) ... Lawrence Tallon, Chief Executive of the MHRA, said..
Edit

MHRA approves zapomeran (Kostaive) mRNA COVID-19 vaccine (MHRA - Medicines and Healthcare products Regulatory Agency)

Public Technologies 02 Jan 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 2 January 2026, approved zapomeran (Kostaive) mRNA COVID-19 vaccine, for the immunisation of individuals aged 18 years of age and older.

Article Search

tools
×
×
×
×